
Pharmaceutical Technology Europe
Crunch time is rapidly approaching in Roquette?s long-running patent dispute with SPI Pharma, with the case scheduled to go to trial on 4th October 2010.

Pharmaceutical Technology Europe
Crunch time is rapidly approaching in Roquette?s long-running patent dispute with SPI Pharma, with the case scheduled to go to trial on 4th October 2010.

Pharmaceutical Technology Europe
Changes to Part 2 of the EU GMP guide will come into force by 31 July 2010 in order to bring it in line with the ICH Q9 guideline on Quality Risk Management. As a result, it will no longer be identical to the ICH Q7 guideline on APIs - a harmonised guideline for the US, Europe and Japan.

Pharmaceutical Technology Europe
Eli Lilly has made a move into enzyme replacement therapy by acquiring Alnara Pharmaceuticals, whose pancreatic enzyme replacement therapy, liprotamase, is currently under review by the FDA for the treatment of exocrine pancreatic insufficiency.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Last week, Senator Charles Grassley (R-IA) sent letters to 16 drugmakers, including Pfizer (New York), AstraZeneca (London), and Eli Lilly (Indianapolis), asking them about their current policies regarding whistleblowers?employees who file complaints under the False Claims Act (FCA).

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US House of Representatives passed on July 1, 2010, HR 4899, the Supplemental Appropriations Act of 2010, which included provisions restricting patent settlements between innovator-drug and generic-drug companies, a move that drew criticism from both sectors of the pharmaceutical industry.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Ethics Group Calls on FTC to Investigate Drug Pricing

ePT--the Electronic Newsletter of Pharmaceutical Technology
Eli Lilly to Acquire Alnara Pharmaceuticals; Exelixis CEO Leaves for Biogen Idec; And More.

PTSM: Pharmaceutical Technology Sourcing and Management
A roundup of developments on corporate social responsibility from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

PTSM: Pharmaceutical Technology Sourcing and Management
Led by sustainability efforts by Walmart, a new tool emerges for quickly evaluating the environmental and human-health profile of formulated products.

PTSM: Pharmaceutical Technology Sourcing and Management
Acumen Fund, a nonprofit venture-capital fund, uses patient capital to build economically sustainable businesses involved in poverty alleviation.

Pharmaceutical Technology Europe
The merger Novartis has been trying to unilaterally impose on Alcon cannot go ahead without the approval of Alcon's Independent Director Committee (IDC), according to a legal expert, and at the moment the IDC still believes that Novartis's offer is vastly inadequate.

To continue innovating, the biopharmaceutical sector needs support from all levels.

As generic divisions become the most-wanted acquisitions of Big Pharma, India's domestic industry may be thinning out.

Reports of overlooked controls, dropped pallets, and misplaced documents leave a chill in the air.

After a spate of industrial disasters, the public seeks greater oversight of corporations-so does FDA.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Pfizer Suspends Tanezumab Program; Actavis Appoints CEO; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration's website now features a free online 90-minute training program on the "Past, Present, and Future of FDA Human Drug Regulation."

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration issued on June 25 a draft guidance for industry, "CMC Postapproval Manufacturing Changes Reportable in Annual Reports," to provide recommendations to drug applicants about the types of changes that may be included in annual reports.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The Office of the Inspector General for the Department of Health and Human Services (HHS) issued a report, Challenges to FDA's Ability to Monitor and Inspect Foreign Clinical Trials, which evaluates the incidence of foreign clinical trials, the ability of the US Food and Drug Administration to oversee these trials, and recommendations to FDA on how to improve its oversight of foreign clinical trials.

Pharmaceutical Technology Europe
We decided to dedicate this month's issue of PTE to a topic that affects all of our readers; the threat of counterfeit medicines.

Pharmaceutical Technology Europe
Teva Pharmaceuticals in the US has admitted to including false statements in the physician prescribing information for its oral contraceptive product Gianvi, a generic version of Bayer Healthcare?s YAZ oral contraceptive.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Valeant and Biovail to Merge; GPhA Names Interim Director; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
European pharmaceutical companies are outdoing their US counterparts when it comes to making medicines available to developing countries, according to the Access to Medicine Index, which analyzes and ranks the access to medicine efforts of the world's largest pharma companies.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Medicines Agency and the European Monitoring Center for Drugs and Drug Addiction to Cooperate.

ePT--the Electronic Newsletter of Pharmaceutical Technology
GSK Acquires Laboratorios Phoenix; Catalent Makes Executive Appointments; And More.

PTSM: Pharmaceutical Technology Sourcing and Management
The American Association for the Advancement of Science rolls out several initiatives to increase partnerships and communication on human rights between scientific groups and between scientific and human rights groups.

PTSM: Pharmaceutical Technology Sourcing and Management
A roundup of developments on corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other organizations.

ePT--the Electronic Newsletter of Pharmaceutical Technology
A study conducted by the European Medicines Agency (EMA) has shown that statistical methods using EMA's EudraVigilance database of adverse drug reaction reports can be used to detect drug safety issues "significantly earlier" compared with routine pharmacovigilance.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Thermo Fisher to Acquire Fermentas; Pfizer Names Head of R&D; And More.